Plain-English translation of NCT07138898 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing the best timing for pausing immunosuppressant medications โ drugs that calm down an overactive immune system โ before and after shoulder replacement surgery in people with rheumatic diseases like rheumatoid arthritis. Right now, doctors don't have clear guidelines for shoulder surgery the way they do for hip and knee surgery, so this trial will compare two different schedules: pausing the medication for a longer time versus a shorter time. The study will track whether differences in timing affect infection risk, wound healing, pain, function, and disease flares.
People with rheumatic diseases need to take immunosuppressant medications to manage their conditions, but these drugs can increase infection risk during surgery. While doctors have established guidelines for hip and knee surgery, there's uncertainty about the safest approach for shoulder replacement โ specifically, how long to pause these medications before surgery and when to restart them afterward.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to one of two groups: one that follows the standard medication hold schedule (longer pause) or one that uses a shorter hold schedule. Your rheumatologist will coordinate with the surgical team to determine exactly when to stop and restart your medications based on your specific drugs. You'll undergo your shoulder replacement surgery as planned, and the study team will monitor you for wound healing, infections, pain levels, physical function, and any disease flares โ tracking these outcomes over your recovery period.
AI-generated summary from trial data ยท Jul 11, 2026 ยท Not medical advice
United States